Bayesian Capital Management, LP Horizon Therapeutics Public LTD CO Transaction History

Bayesian Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $1.44 Million - $2.11 Million	-18,100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $1.56 Million - $1.99 Million	18,100 New	18,100 $1.9 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $2.79 Million - $3.71 Million	-38,900 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $1.1 Million - $1.38 Million	16,400 Added 72.89%	38,900 $2.85 Million
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $171,213 - $247,783	3,100 Added 15.98%	22,500 $1.75 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $211,400 - $398,860	-7,000 Reduced 26.52%	19,400 $1.08 Million
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $656,568 - $1.02 Million	26,400 New	26,400 $782,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.